Andrew Craig Miller - Dec 1, 2022 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Operating Officer
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Dec 1, 2022
Transactions value $
-$3,421,223
Form type
4
Date filed
12/2/2022, 04:00 PM
Previous filing
Nov 14, 2022
Next filing
Dec 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $1.82K +250 +0.98% $7.27* 25.8K Dec 2, 2022 Direct
transaction KRTX Common Stock Options Exercise $1.46K +500 +1.94% $2.92* 26.3K Dec 2, 2022 Direct
transaction KRTX Common Stock Sale -$3.42M -15K -57.14% $228.30 11.3K Dec 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -250 -2.11% $0.00 11.6K Dec 2, 2022 Common Stock 250 $7.27 Direct F2
transaction KRTX Option (right to buy) Options Exercise $0 -500 -0.9% $0.00 54.9K Dec 2, 2022 Common Stock 500 $2.92 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2022.
F2 This option vested as to 1/30th of the shares underlying the option award on each one month anniversary of the vesting commencement date of August 15, 2018.
F3 This option vested as to 1/16th of the shares underlying the option award on the vesting commencement date of July 18, 2016 and as to an additional 1/16th of the shares on each three month anniversary thereafter.